Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

7 pts

Opinion on ViroPharma Inc (VPHM) Sector: Healthcare > Industry: Biotechnology & Drugs
Camvia & Vancocin & The Baker Brothers

Nov 11, 2007 03:44 AM GMT

Bill German

Return	Risk
-33.79%	HIGH

Analyst

Profile & Performance

Subscribe to author

Reasons to buy:

1. Baker Brothers bought 900,000 shares on Nov 8,2007

2. Camvia Phase III trials could be very promising with FDA Orphan status

3. Possible increase in demand for Vancocin even with generic due out in 2008?

VPHM: This call was made on 11/11/07 @ $7.98

Rating:	$7.98 (11/11/07)
Gain/Loss:	+1.13% in 754 days
Target:	$15.00 (+87.97%) in > one year
Allocation:	12.7% of portfolio

+ Referring to this analysis:

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

Who voted on this idea?

abe Loren

61%

11/27/2007

Ratings referring to this analysis

Agree

Disagree

Bearish on VPHM ...
abe Loren 11/27/2007

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.44%	381
2	Gerald Greene	18.14	+71.24%	211
3	stockmarketfunding.com	17.66	+25.60%	55
4	akiralegrand	13.47	+14.32%	62
5	anup2104	12.13	+74.22%	40

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
WM	Washington Mutual Inc
IBM	International Business Machines Corp
POT	Potash Corp. of Saskatchewan Inc.
PFE	Pfizer Inc
XOM	Exxon Mobil Corp
F	Ford Motor Company

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

DNDN		Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: D... by Mike Havrilla
CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev

... more »

ViroPharma Inc (VPHM)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

97.5%

Top:

100.0%

Get Daily Email Alerts

Subscribe to Bill German

Receive Free Ideas Daily for This Sector

Latest Picks by Bill German

Symbol	SP Sentiment	Return	Since
CCIX	N/A	-69.86%	02/01/08
INCY		-33.03%	02/01/08
RDEA	N/A	-1.41%	12/22/07
BCON		-65.78%	11/11/07
GVHR	N/A	n/a	11/11/07

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on ViroPharma Inc (VPHM) Sector: Healthcare > Industry: Biotechnology & Drugs Camvia & Vancocin & The Baker Brothers

Opinion on ViroPharma Inc (VPHM) Sector: Healthcare > Industry: Biotechnology & Drugs
Camvia & Vancocin & The Baker Brothers